Who are Povidone's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Pre-Op, Multiple cardiovascular drugs related to "Golden Triangle", Povidone-Iodine 10%, POVIDONE, Chlorhexidine gluconate (4%), The Chlorhexidine gluconate 0.05%.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/crospovidone.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Povidone — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Povidone (CROSPOVIDONE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antiseptic [EPC]. Area: Ophthalmology.

marketed Antiseptic [EPC] Ophthalmology Live · refreshed every 30 min

Target snapshot

Povidone (CROSPOVIDONE).

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Povidone TARGET	CROSPOVIDONE		marketed	Antiseptic [EPC]
Pre-Op	HEXACHLOROPHENE	Davis And Geck	marketed	Antiseptic	N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D, 78 kDa glucose-regulated protein, Adenosine receptor A3	1949-01-01
Multiple cardiovascular drugs related to "Golden Triangle"	Multiple cardiovascular drugs related to "Golden Triangle"	Sun Yat-sen University	marketed	Antiseptic [EPC]
Povidone-Iodine 10%	Povidone-Iodine 10%	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	marketed	Antiseptic [EPC]
POVIDONE	POVIDONE		marketed	Antiseptic [EPC]
Chlorhexidine gluconate (4%)	Chlorhexidine gluconate (4%)	The Cooper Health System	marketed	Antimicrobial agent / Antiseptic
The Chlorhexidine gluconate 0.05%	The Chlorhexidine gluconate 0.05%	HaEmek Medical Center, Israel	marketed	Antimicrobial agent / Antiseptic

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antiseptic [EPC] class)

· 2 drugs in this class
Cliniques universitaires Saint-Luc- Université Catholique de Louvain · 1 drug in this class
Erzincan Military Hospital · 1 drug in this class
Sun Yat-sen University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Povidone — Competitive Intelligence Brief. https://druglandscape.com/ci/crospovidone. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing